Clinical Trial Update: Optimum Platelet Inhibition After Coronary Bypass Surgery [NA]

View source ↗

Summary

The document provides a status update on a completed clinical trial comparing strategies for optimal platelet inhibition after coronary bypass surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Snippet

Sponsor: Papworth Hospital NHS Foundation Trust | Conditions: Ischemic Heart Disease | NA | Status: COMPLETED